Tough conditions for these companies left them out of the day's rally.
News & Analysis: Mallinckrodt
The company filed a lawsuit to stop a federal decision that could be very bad news for its top drug.
Forty-four states have brought a lawsuit against the industry.
MNK earnings call for the period ending March 31, 2019.
Poor earnings and other business threats hurt these stocks.
Downbeat news from several sources hurt these stocks.
MNK earnings call for the period ending December 28, 2018.
The pharma company announced fourth-quarter and full-year 2018 operating results.
A negative tweet from a noted short-seller caused the drug stock to tumble.
MNK earnings call for the period ending September 30, 2018.